Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)
Clinical trial NCT01617655 · COMPLETED
Trial details
- NCT number
- NCT01617655
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-05-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.